• Advisors

  • Appu Rathinavelu, Ph.D

  • Executive Director, Rumbaugh-Goodwin Institute for Cancer Research
    Nova Southeastern University, 3301 College Avenue, Fort-Lauderdale-Davie, Florida 33314-7796.

    Appu Rathinavelu, Ph.D. has been involved in cancer research since 1992, and under his leadership as Executive Director, NSU’s Rumbaugh-Goodwin Institute for Cancer Research, is conducting groundbreaking research on new cancer therapeutics and powerful diagnostic methods for breast, lung, pancreatic and colorectal cancers. Rathinavelu’s work also includes identification of gene defects and cellular mechanisms that enhance cancer spreading and drug resistance. He has published more than 30 peer-reviewed research articles, served as reviewer for scientific publications, co-authored a text book and given more than 75 presentations at national and international conferences. Rathinavelu received his Ph.D. in biochemistry from the University of Madras and conducted his postdoctoral training at Purdue University. In 1992, he joined the Department of Pharmaceutical Sciences at Southeastern University’s College of Pharmacy, and he is currently chairman of the Department of Pharmaceutical and Administrative Sciences at NSU’s College of Pharmacy.

  • Ilya Trakht, Ph.D

  • Director Cell Culture and Hybridoma Laboratory (earlier), Associate Research Scientist, Department of Medicine, College of Physicians and Surgeons of Columbia University. Dr. Trakht has a background in Immunology, Biochemistry and Cell Biology his primary interests have been and remain in these fields specifically the mechanism of immune response in cancer. With his colleagues he developed a method to generate fully human monoclonal antibodies (fhMAB) to cancer cells using patients’ own immune cells. While the potential use of fhMAB as immunotherapeutics represent passive immunotherapy, his interests lately also expanded into the area of active immunotherapy such cancer vaccines. Dr. Trakht has PhD in, Biochemistry, Cell Biology, and Immunology.

  • Sundararajah Thevananther, Ph.D.

  • Associate Professor, Department of Pediatrics and Molecular & Cellular Biology, Baylor College of Medicine, Houston, Texas. Dr. Thevananther has Ph.D in Biochemistry from Bowling Green State University, Ohio, completed his postdoctoral fellowship at Yale University School of Medicine, New haven, Connecticut. He is doing research interest in in liver regereation, fatty liver disease and hepatocellular carcinoma.